CLDN18.2-positive tumors
Showing 1 - 25 of >10,000
Advanced Solid Tumor Trial in Chengdu (Dual-targeting CLDN18.2 and PD-L1 CAR-T cells)
Not yet recruiting
- Advanced Solid Tumor
- Dual-targeting CLDN18.2 and PD-L1 CAR-T cells
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Oct 9, 2023
Advanced Solid Tumor Trial in Shanghai (IMC008)
Recruiting
- Advanced Solid Tumor
-
Shanghai, Shanghai, ChinaShanghai Changhai Hospital
Apr 19, 2023
Gastric Cancer, Pancreatic Cancer, Advanced Ovarian Carcinoma Trial (Claudin 18.2 CAR-T)
Not yet recruiting
- Gastric Cancer
- +3 more
- Claudin 18.2 CAR-T
- (no location specified)
Jul 21, 2022
Metastatic Solid Tumor Trial (TAC01-CLDN18.2)
Not yet recruiting
- Metastatic Solid Tumor
- TAC01-CLDN18.2
- (no location specified)
May 8, 2023
Locally Advanced Unresectable or Metastatic Solid Tumors Trial in China (SG1906)
Recruiting
- Locally Advanced Unresectable or Metastatic Solid Tumors
-
Beijing, Beijing, China
- +8 more
May 12, 2023
Solid Tumor Trial in Beijing (QLS31905, Nab paclitaxel, Gemcitabine)
Not yet recruiting
- Solid Tumor
- QLS31905
- +5 more
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Sep 10, 2023
Solid Tumor, Adult Trial in Wuxi (89Zr-NY005)
Not yet recruiting
- Solid Tumor, Adult
-
Wuxi, Jiangsu, ChinaWuxi No. 4 People's Hospital
Jul 23, 2021
Solid Tumor, Gastric Cancer, Pancreatic Adenocarcinoma Trial in China (AB011 Injection)
Recruiting
- Solid Tumor
- +2 more
- AB011 Injection
-
Hefei, Anhui, China
- +11 more
Feb 7, 2022
Solid Tumor, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Canada, Spain, United States (BNT141,
Recruiting
- Solid Tumor
- +7 more
- BNT141
- +2 more
-
Duarte, California
- +10 more
Aug 23, 2022
Solid Tumor Trial in Suzhou (IBI345)
Recruiting
- Solid Tumor
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Jan 6, 2022
Advanced Solid Tumor Trial in Shanghai (LM-302 Injection)
Recruiting
- Advanced Solid Tumor
- LM-302 Injection
-
Shanghai, Shanghai, ChinaShanghai East Hospital
Dec 29, 2021
Gastric Cancer, Pancreatic Cancer, Solid Tumor Trial in Beijing (KD-496)
Not yet recruiting
- Gastric Cancer
- +2 more
- KD-496
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Nov 15, 2023
Gastric Cancer, Pancreatic Cancer, Solid Tumor Trial in Beijing (KD-496)
Recruiting
- Gastric Cancer
- +2 more
- KD-496
-
Beijing, ChinaChinese PLA General Hospital
Oct 13, 2022
Gastrointestinal Tumors Trial in Beijing (AZD6422 CLDN18.2 CAR-T product)
Not yet recruiting
- Gastrointestinal Tumors
- AZD6422 CLDN18.2 CAR-T product
-
Beijing, ChinaBeijing Cancer Hospital
Aug 1, 2023
Advanced Solid Tumor Trial in Shanghai (LM-102 Injection, LM-102 Injection combined with SOC)
Recruiting
- Advanced Solid Tumor
- LM-102 Injection
- LM-102 Injection combined with SOC
-
Shanghai, Shanghai, ChinaFudan Zhongshan Hospital
Nov 5, 2021
Gastric Cancer, Pancreatic Cancer Trial (LM302+Toripalimab)
Not yet recruiting
- Gastric Cancer
- Pancreatic Cancer
- (no location specified)
Jun 28, 2023
Gastrointestinal Cancer Trial in Beijing (124I-18B10(10L) PET/CT)
Recruiting
- Gastrointestinal Cancer
- 124I-18B10(10L) PET/CT
-
Beijing, ChinaHUA ZHU
Jul 18, 2022
Solid Tumor Trial in Chuo Ku (SAIL66, Tocilizumab)
Not yet recruiting
- Solid Tumor
-
Chuo Ku, Tokyo, JapanNational Cancer Center Hospital
Feb 9, 2023
Gastrointestinal Cancer Trial in Beijing (Intravenous injection of 68Ga-PMD22)
Recruiting
- Gastrointestinal Cancer
- Intravenous injection of 68Ga-PMD22
-
Beijing, ChinaPeking Union Medical College Hospital, Chinese Academy of Medica
Jun 30, 2023
Advanced Digestive System Tumor Trial in China (IMC001 injection)
Not yet recruiting
- Advanced Digestive System Tumor
- IMC001 injection
-
Beijing, Beijing, China
- +6 more
Jul 12, 2023